Na Chang
- Molecular Biology top 10%
- Immunology top 10%
- Epidemiology top 10%
- Cancer Research top 10%
- Hepatology top 5%
- Topics
- Immune cells in cancer (12 papers)Liver physiology and pathology (9 papers)Sphingolipid Metabolism and Signaling (9 papers)
- Cited by
- HepatologyCancer ResearchImmunology
- Partner nations
- ChinaPolandUnited States
In The Last Decade
Na Chang
46 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 114
- Molecular Biology 902
- Immunology 322
- Epidemiology 303
- Cancer Research 289
- Hepatology 217
Countries citing papers authored by Na Chang
This map shows the geographic impact of Na Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Chang more than expected).
Fields of papers citing papers by Na Chang
This network shows the impact of papers produced by Na Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Chang. The network helps show where Na Chang may publish in the future.
Co-authorship network of co-authors of Na Chang
This figure shows the co-authorship network connecting the top 25 collaborators of Na Chang. A scholar is included among the top collaborators of Na Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Chang. Na Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 38 | |
| 6 | 14 | |
| 7 | 2 | |
| 8 | 23 | |
| 9 | 64 | |
| 10 | 6 | |
| 11 | 38 | |
| 12 | 84 | |
| 13 | 19 | |
| 14 | 88 | |
| 15 | 6 | |
| 16 | 103 | |
| 17 | 8 | |
| 18 | 84 | |
| 19 | 25 | |
| 20 | 46 |
About Na Chang
Na Chang is a scholar working on Hepatology, Immunology and Cancer Research, having authored 47 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune cells in cancer (12 papers), Liver physiology and pathology (9 papers) and Sphingolipid Metabolism and Signaling (9 papers). The work is most often cited by research in Hepatology (217 citations), Cancer Research (289 citations) and Immunology (322 citations). Na Chang has collaborated with scholars based in China, Poland and United States. Frequent co-authors include Liying Li, Le Yang, Lin Yang, Weiyang Li, Jianlei Zhang, Xuan Zhou, Lin Yang, Fangfang Zhao, Xinhao Zhao and Lei Hou. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.